[Hemomediastinum 10 days after pulmonary embolectomy under extracorporeal circulation and 36 hours after the start of treatment with urokinase].
D010450:Endopeptidases / Q000009:adverse effects*; D005112:Extracorporeal Circulation; D005260:Female; D006491:Hemothorax / Q000209:etiology*; D006801:Humans; D008875:Middle Aged; D011655:Pulmonary Embolism / Q000188:drug therapy / Q000601:surgery*; D014568:Urokinase-Type Plasminogen Activator / Q000009:adverse effects* / Q000627:therapeutic use
D010450:Endopeptidases; D014568:Urokinase-Type Plasminogen Activator
Hémo-médiastin dix jours après une embolectomie pulmonaire sous CEC et 36 heures après le début d'un traitement à l'urokinase